1st Pharmaron Symposium In DMPK And Biology Was Held On May 30, 2015 - Pharmaron

BEIJING – May 30, 2015. Pharmaron held the 1st Pharmaron Symposium in DMPK & Biology. DMPK and biology are two critical components for drug discovery and development. This First International Symposium aimed to bring together highly sought–after speakers from all over the world to speak at Pharmaron Beijing. At this significant event, leaders from both academia and biopharmaceutical industry presented advances that showcase how DMPK and biology have interacted with each other, which, in turn, has fundamentally reshaped the modern drug R&D process. The Symposium also served as a training platform to strengthen Pharmaron’s integrated R&D abilities, gained additional insight about the development of the industry, and deepened understanding of DMPK and Biology.

Featured Speakers

Dr. Jonathan Huw Connick

Executive Director, Research Science at Merck University of California, Berkeley, USA and MSD China

Dr. David C. Evans

Vice President, Head Global Pharmacokinetics, Dynamics & Metabloism, Janssen R&D, Johnson & Johnson USA

Dr. Vincent Jaquet

University of Geneva, Rue de Fribourg 5, 1201 Geneve

Switzerland

Dr. Barry C. Jones

Senior Principal Scientist, DMPK, Astrazeneca

UK

Dr. Yue Ma

Institute of Biophysics, Chinese Academy of Sciences China

Prof. Jufeng Wang

Director National Center for Safety Evaluation of Drugs, National Institutes for food and Drug Control China